PREPARATION OF RAT-BRAIN MEMBRANES HIGHLY ENRICHED WITH OPIATE KAPPA BINDING-SITES USING SITE-DIRECTED ACYLATING AGENTS - OPTIMIZATION OF ASSAY CONDITIONS

被引：38
作者：
ROTHMAN, RB
BYKOV, V
DANKS, JA
JACOBSON, AE
BURKE, TR
RICE, KC
HERKENHAM, M
机构：
[1] NIMH,NEUROPHYSIOL LAB,BETHESDA,MD 20205
[2] ST ELIZABETHS HOSP,NIMH,OVERHOLLSER DIV TRAINING,WASHINGTON,DC 20032
[3] NIADDK,CHEM LAB,BETHESDA,MD 20205
来源：
NEUROPEPTIDES | 1985年 / 6卷 / 06期
关键词：
D O I：
10.1016/0143-4179(85)90112-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：503 / 516
页数：14
相关论文
共 23 条
[1]   INTERCONVERTING MU-FORMS AND DELTA-FORMS OF THE OPIATE RECEPTOR IN RAT STRIATAL PATCHES [J].
BOWEN, WD ;
GENTLEMAN, S ;
HERKENHAM, M ;
PERT, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :4818-4822
[2]   DYNORPHIN1-8 AND DYNORPHIN1-9 ARE LIGANDS FOR THE KAPPA-SUBTYPE OF OPIATE RECEPTOR [J].
CORBETT, AD ;
PATERSON, SJ ;
MCKNIGHT, AT ;
MAGNAN, J ;
KOSTERLITZ, HW .
NATURE, 1982, 299 (5878) :79-81
[3]   K-OPIATE RECEPTORS LOCALIZED BY AUTORADIOGRAPHY TO DEEP LAYERS OF CEREBRAL-CORTEX - RELATION TO SEDATIVE EFFECTS [J].
GOODMAN, RR ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (18) :5703-5707
[4]  
HERKENHAM M, 1982, J NEUROSCI, V2, P1129
[5]   SOLUBILIZATION AND CHARACTERIZATION OF MU-OPIOID, DELTA-OPIOID, AND KAPPA-OPIOID BINDING-SITES FROM GUINEA-PIG BRAIN - PHYSICAL SEPARATION OF KAPPA-RECEPTORS [J].
ITZHAK, Y ;
HILLER, JM ;
SIMON, EJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (13) :4217-4221
[6]   A PROTEIN-LIPID MODEL OF THE OPIATE RECEPTOR [J].
LEE, NM ;
SMITH, AP .
LIFE SCIENCES, 1980, 26 (18) :1459-1464
[7]   [H-3]-LABELED SUFENTANIL, A SUPERIOR LIGAND FOR MU-OPIATE RECEPTORS - BINDING-PROPERTIES AND REGIONAL DISTRIBUTION IN RAT-BRAIN AND SPINAL-CORD [J].
LEYSEN, JE ;
GOMMEREN, W ;
NIEMEGEERS, CJE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 87 (2-3) :209-225
[8]  
MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517
[9]  
MCKNIGHT AT, 1984, NEUROPEPTIDES, V5, P97, DOI 10.1016/0143-4179(84)90036-2
[10]  
PERT CB, 1974, MOL PHARMACOL, V10, P868
123